Multi-centric clinical study in patients with stage 5 chronic kidney disease (CKD) receiving a living donor kidney Study of MIC-Lx cell treatment, a potentially curative approach to achieve sustained immune tolerance in transplanted and autoimmune patients as shown in previous Phase Ib study TolerogenixX GmbH, a biopharmaceutical company developing personalized cellular therapies aimed at […]